Loveleen Bansi‐Matharu

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models

Britta L. Jewell, Edinah Mudimu, John Stover et al. · The Lancet HIV · 2020 · 417 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Sustainable HIV treatment in Africa through viral-load-informed differentiated care

Andrew Phillips, Amir Shroufi, Lara Vojnov et al. · Nature · 2015 · 168 citations · Full text

Public Health, Infectious Diseases, Pharmacoeconomics +17

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

Bastian Neesgaard, Lauren Greenberg, José M. Miró et al. · The Lancet HIV · 2022 · 136 citations · Full text

Public Health, Cardiology, Internal Medicine +17

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

Andrew Phillips, François Venter, Diane V. Havlir et al. · The Lancet HIV · 2018 · 127 citations · Full text

Public Health, Health Policy, Pharmacology +17

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

Andrew Phillips, Loveleen Bansi‐Matharu, Valentina Cambiano et al. · The Lancet Global Health · 2021 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17